AMD is a major health problem. Currently, clinical AMD is more prevalent than glaucoma and diabetic retinopathy combined—and by the year 2050, it is estimated to double, according to research published in Archives of Ophthalmology.
Hear from several experts, including Miguel A. Busquets, MD, Carolyn Majcher, OD, and Mary Anne C. Murphy, OD, about how to manage geographic atrophy using modern-day tools, technology, treatments and knowledge.
Sponsored by Apellis Pharmaceuticals Inc and Carl Zeiss Meditec USA, Inc